These early results showed that the vaccine worked to trigger an immune response with mild side effects: fatigue, chills, headache, muscle pain, pain at the injection site. But the vaccine will still have to pass a large Phase 3 trial, expected to begin later this month, before regulators consider whether …
Read More »